HOBOKEN UNIVERSITY MEDICAL CENTER — History
CCN 310040 | 3-year financial timeline | COVID resilience: 23/100
🛡️ Public data only — no PHI permitted on this instance.
$134M
Latest Revenue (FY2022)
-6.2%
Revenue CAGR (3yr)
-48.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $152M | $152M | $134M | -11.9% | -6.2% |
| Operating Expenses | $190M | $187M | $199M | +6.5% | +2.4% |
| Operating Margin | -24.9% | -23.1% | -48.9% | -111.4% | +0.0% |
| Net Income | $-38M | $-35M | $-66M | -86.2% | +0.0% |
| Licensed Beds | 117 | 114 | 114 | +0.0% | -1.3% |
| Total Patient Days | 21,839 | 19,516 | 17,751 | -9.0% | -9.8% |
| Medicare Day % | 21% | 20% | 17% | -14.8% | -10.3% |
| Medicaid Day % | 6% | 4% | 4% | -16.0% | -23.9% |
COVID Impact & Recovery
Resilience Score: 23/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -12.0% ($152M → $134M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-6.2%
This Hospital
+7.6%
State Avg
Latest Margin
-48.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $125M | -60.9% |
| FY2024 (proj) | $116M | -72.9% |
| FY2025 (proj) | $106M | -84.9% |